TcMS to Treat Ventricular Tachycardia

Transcutaneous Magnetic Stimulation of the Stellate Ganglion to Treat Ventricular Tachycardia

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05016921

Enrollment

Registered

2021-08-23

Start date

2024-01-01

Completion date

2024-01-01

Last updated

2024-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular Tachycardia

Brief summary

Open label study of transcutaneous magnetic stimulation targeting the stellate ganglion in patients with ventricular tachycardia

Interventions

DEVICETcMS

Transcutaneous magnetic stimulation targeting the stellate ganglion

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \>18years * Documented ventricular tachycardia within the preceding 72 hours

Exclusion criteria

* Pregnancy * Implanted ventricular assist device * Metal implanted in heard or neck (except the mouth) * Implanted medication pumps * Cochlear implant * Implanted brain stimulator * Ocular implant * History of malignancy in the region of stimulation (neck)

Design outcomes

Primary

Measure	Time frame	Description
Ventricular Tachycardia	0-72 hours after enrollment	Burden (number of episodes) of ventricular tachycardia

Secondary

Measure	Time frame	Description
Non sustained ventricular tachycardia	0-72 hours after enrollment	Burden (number of episodes) of ventricular tachycardia
Discomfort	Assessed immediately following stimulation	Discomfort experienced during stimulation (on scale of 0-10) reported by patient

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026